Patterns and modes of β-lactam resistance in Pseudomonas aeruginosa
- 1 March 1999
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 5, S15-S18
- https://doi.org/10.1111/j.1469-0691.1999.tb00719.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Extended-spectrum beta-lactamases in Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1998
- OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1997
- Pseudomonas aeruginosa isolates from patients with cystic fibrosis have different beta-lactamase expression phenotypes but are homogeneous in the ampC-ampR genetic regionAntimicrobial Agents and Chemotherapy, 1997
- Carbapenem resistance in Pseudomonas aeruginosa from cystic fibrosis patientsJournal of Antimicrobial Chemotherapy, 1996
- Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B β-lactamaseJournal of Antimicrobial Chemotherapy, 1996
- Antibodies against Pseudomonas aeruginosa chromosomal β-lactamase in patients with cystic fibrosis are markers of the development of resistance of P. aeruginosa to β-lactamsJournal of Antimicrobial Chemotherapy, 1995
- Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1992
- High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatmentAntimicrobial Agents and Chemotherapy, 1992
- Decreased outer membrane permeability in imipenem-resistant mutants of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1989
- Resistance to Imipenem in Pseudomonas aeruginosa: Clinical Experience and Biochemical MechanismsClinical Infectious Diseases, 1988